Dr. Jufeng Wang 王居峰
Chief Physician
Department of Integrated Traditional Chinese and Western Medicine Oncology, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and medical treatment of gastrointestinal tumors (gastric, colorectal, esophageal cancers), lymphoma, and lung cancer.
Dr. Wang is Deputy Director of Internal Medicine and Director of Internal Medicine Ward 1 at Henan Cancer Hospital. Holding a Master of Medicine, Dr. Wang graduated from Henan University of Science and Technology School of Medicine in 1987 and completed a master’s in gastroenterology at Henan Medical University in 1995. Dr. Wang has published over 20 papers, participated in 4 research projects, co-authored 3 books, and received 5 scientific achievement awards.
Name order: in Chinese the family name comes first (Wang Jufeng). Papers usually list the name as Jufeng Wang or Wang J.
Selected publications
40 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2024 (senior author): Corrigendum: Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy. PubMed 38915365
- Biochem Genet, 2023 (senior author): NREP is a Diagnostic and Prognostic Biomarker, and Promotes Gastric Cancer Cell Proliferation and Angiogenesis. PubMed 36094607
- Front Oncol, 2023 (senior author): Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy. PubMed 36998452
- Ann Transl Med, 2022 (senior author): The value of the Advanced Lung Cancer Inflammation Index (ALI) in assessing the prognosis of patients with hepatocellular carcinoma treated with camrelizumab: a retrospective cohort study. PubMed 36544677
- J Gastrointest Oncol, 2021 (senior author): Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma. PubMed 34790394
- Cancer Manag Res, 2021 (senior author): Long Noncoding RNA GAS5 Accelerates Cholangiocarcinoma Progression by Regulating hsa-miR-1297. PubMed 33790648
- Pathol Oncol Res, 2020 (senior author): PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma. PubMed 30374621
- Mol Med Rep, 2018 (senior author): Effects of obatoclax combined with gemcitabine on the biological activity of pancreatic cancer cells under hypoxic conditions. PubMed 29749486
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion